ITUB20152109A1 - Nucleosidi fosforamidati utili per il trattamento di infezioni virali e loro preparazione - Google Patents

Nucleosidi fosforamidati utili per il trattamento di infezioni virali e loro preparazione

Info

Publication number
ITUB20152109A1
ITUB20152109A1 ITUB2015A002109A ITUB20152109A ITUB20152109A1 IT UB20152109 A1 ITUB20152109 A1 IT UB20152109A1 IT UB2015A002109 A ITUB2015A002109 A IT UB2015A002109A IT UB20152109 A ITUB20152109 A IT UB20152109A IT UB20152109 A1 ITUB20152109 A1 IT UB20152109A1
Authority
IT
Italy
Prior art keywords
preparation
treatment
viral infections
nucleosides useful
phosphoramidate nucleosides
Prior art date
Application number
ITUB2015A002109A
Other languages
English (en)
Inventor
Giuseppe Barreca
Marcello Rasparini
Andrea Poggiali
Luca Carcone
Roberto Rocco Tufaro
Giovanni Marras
Maurizio Taddei
Elena Cini
Original Assignee
Quim Sintetica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quim Sintetica S A filed Critical Quim Sintetica S A
Priority to ITUB2015A002109A priority Critical patent/ITUB20152109A1/it
Priority to EP16726151.0A priority patent/EP3274356A1/en
Priority to PCT/IB2016/051710 priority patent/WO2016151542A1/en
Priority to US15/560,862 priority patent/US10407456B2/en
Publication of ITUB20152109A1 publication Critical patent/ITUB20152109A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
ITUB2015A002109A 2015-03-26 2015-07-13 Nucleosidi fosforamidati utili per il trattamento di infezioni virali e loro preparazione ITUB20152109A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITUB2015A002109A ITUB20152109A1 (it) 2015-07-13 2015-07-13 Nucleosidi fosforamidati utili per il trattamento di infezioni virali e loro preparazione
EP16726151.0A EP3274356A1 (en) 2015-03-26 2016-03-25 Nucleoside phosphoramidates useful for the treatment of viral infections and preparation thereof
PCT/IB2016/051710 WO2016151542A1 (en) 2015-03-26 2016-03-25 Nucleoside phosphoramidates useful for the treatment of viral infections and preparation thereof
US15/560,862 US10407456B2 (en) 2015-03-26 2016-03-25 Nucleoside phosphoramidates useful for the treatment of viral infections and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2015A002109A ITUB20152109A1 (it) 2015-07-13 2015-07-13 Nucleosidi fosforamidati utili per il trattamento di infezioni virali e loro preparazione

Publications (1)

Publication Number Publication Date
ITUB20152109A1 true ITUB20152109A1 (it) 2017-01-13

Family

ID=54364474

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUB2015A002109A ITUB20152109A1 (it) 2015-03-26 2015-07-13 Nucleosidi fosforamidati utili per il trattamento di infezioni virali e loro preparazione

Country Status (1)

Country Link
IT (1) ITUB20152109A1 (it)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008121634A2 (en) * 2007-03-30 2008-10-09 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
WO2010135569A1 (en) * 2009-05-20 2010-11-25 Pharmasset, Inc. N- [ (2 ' r) -2 ' -deoxy-2 ' -fluoro-2 ' -methyl-p-phenyl-5 ' -uridylyl] -l-alanine 1-methylethyl ester and process for its production
WO2012040126A1 (en) * 2010-09-22 2012-03-29 Alios Biopharma, Inc. Substituted nucleotide analogs

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008121634A2 (en) * 2007-03-30 2008-10-09 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
WO2010135569A1 (en) * 2009-05-20 2010-11-25 Pharmasset, Inc. N- [ (2 ' r) -2 ' -deoxy-2 ' -fluoro-2 ' -methyl-p-phenyl-5 ' -uridylyl] -l-alanine 1-methylethyl ester and process for its production
WO2012040126A1 (en) * 2010-09-22 2012-03-29 Alios Biopharma, Inc. Substituted nucleotide analogs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JONG HYUN CHO ET AL: "Efficient synthesis of nucleoside aryloxy phosphoramidate prodrugs utilizing benzyloxycarbonyl protection", TETRAHEDRON, vol. 67, no. 30, 1 July 2011 (2011-07-01), pages 5487 - 5493, XP055092851, ISSN: 0040-4020, DOI: 10.1016/j.tet.2011.05.046 *

Similar Documents

Publication Publication Date Title
IL285060B (en) Enhanced delivery of viral particles to the striatum and cortex
IL266119A (en) Antiviral compositions for the treatment of infections linked to coronaviruses
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
IL280459A (en) Phosphoramidates for the treatment of hepatitis b virus
HUE058737T2 (hu) Eljárások arenaviridae vírusok okozta fertõzések kezelésére
LT3160476T (lt) Pakeistieji nukleozidai, nukleotidai ir jų analogai, skirti naudoti virusinių infekcijų gydyme
EP3331571A4 (en) COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS
SG11201707663SA (en) Lyophilization of rna
DK3512863T3 (da) 2¿-substituerede-N6-substituerede purinnukleotider til behandling af RNA-virus
MA41213A (fr) Nucléosides substitués, nucléotides et analogues de ceux-ci
HRP20181130T1 (hr) Postupci za liječenje infekcija virusom filoviridae
MA41441A (fr) Nucléosides substitués, nucléotides et analogues de ceux-ci
EP3340971A4 (en) METHOD FOR TREATING LENNOX-GASTAUT SYNDROME WITH FENFLURAMINE
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
SI3693367T1 (sl) Tieno(3,2-D)pirimidini, uporabni za zdravljenje okužb z respiratornim sincicijskim virusom
BR112016021629A2 (pt) inibidores de c5a para o tratamento de pneumonia viral
PL3186244T3 (pl) Analogi dioksolanowe urydyny w leczeniu raka
DK3478843T3 (da) Oligonukleotider omfattende modificerede nukleosider
HUE049939T2 (hu) Liposzómák vírusfertõzések kezelésére
WO2015018797A3 (en) Antiviral compounds
RS66408B1 (sr) Postupak za lečenje multiple skleroze
ITUA20161550A1 (it) Procedimento per la produzione di RNA
PL3095866T3 (pl) Środek do profilaktyki i terapii infekcji wirusowych
ITUB20152109A1 (it) Nucleosidi fosforamidati utili per il trattamento di infezioni virali e loro preparazione
SG10202010317VA (en) Pyrimidine prodrugs for the treatment of viral infections and further diseases